Aurora Cannabis Inc. (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has launched Bidiol, the first medical cannabis oil in Uruguay that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10mL and 30mL bottles, available in pharmacies across the country.
“The launch of Bidiol has been two years in the making and is an integral part of our renewed strategy in Uruguay,” said Miguel Martin, Chief Executive Officer of Aurora Cannabis. “We have prioritized key international markets with the potential to meaningfully expand their patient base. Our efforts include working alongside governments and local partners to do what works best in each market. There isn’t a one size fits all strategy – our approach must be smart and domestically relevant.”
A leader in the international cannabis market, Aurora has shifted its strategy in Uruguay to focus exclusively on medical cannabis, with the aim of making the country its continental centre of production and distribution. Aurora’s operation in Uruguay includes one of the only GMP certified cannabis processing facilities in the country.
CBD oil is authorized by the Ministry of Public Health of Uruguay for the treatment of refractory epilepsy in children and adolescents.
Aurora is continuing to develop its CBD oil product line in Uruguay, with plans to expand its portfolio in the coming months.
